[Drug prescriptions study in the outpatient setting: assessment of off-label uses in children]

Encarnación Blanco-Reina1, M Auxiliadora Vega-Jiménez2, Ricardo Ocaña-Riola3

  • 1Departamento de Farmacología y Pediatría, Facultad de Medicina, Universidad de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, España.

Atencion Primaria
|December 3, 2014
PubMed

Insights

Nearly one-third of pediatric outpatients receive off-label or unlicensed prescriptions, often due to age or dosage variations. Improving evidence-based medicine is crucial for safer pediatric drug therapy.

Area of Science:

  • Pediatric Pharmacology
  • Drug Utilization Studies
  • Evidence-Based Medicine

Background:

  • Pediatric patients often receive medications prescribed off-label or unlicensed due to limited approved drug information.
  • Understanding prescription patterns is essential for ensuring safe and effective medication use in children.

Purpose of the Study:

  • To evaluate the prescription profile of non-hospitalized pediatric patients.
  • To assess the prevalence and reasons for off-label and unlicensed medicine use in this population.

Main Methods:

  • Cross-sectional study conducted in pediatric units and an emergency room.
  • Data collected included sociodemographics, reasons for consultation, and therapeutic medication information.
  • Prescriptions were classified based on Summary of Product Characteristics (SPC) requirements.

Main Results:

  • 388 children were included, with an average of 1.7 drugs per child.
  • Most prescribed drugs included ibuprofen, paracetamol, amoxicillin-clavulanate, and budesonide.
  • 27.4% of prescriptions were off-label, primarily due to different age (60%) or dose (21.5%).

Conclusions:

  • A significant proportion of pediatric outpatients are exposed to off-label or unlicensed prescriptions.
  • Off-label use is often based on limited official information, highlighting the need for more research.
  • Encouraging evidence-based medicine and adherence to specific drug regulations is vital for improving pediatric pharmacotherapy.
Abstract

Related Concept Videos

Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
393
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
944
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
518
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
895
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
373